| Product Code: ETC5259932 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In Israel, the pharmaceutical sector is witnessing significant growth, particularly in the area of chemotherapy. The Israel Compounding Chemotherapy Market is characterized by advanced research and development efforts, leading to the production of innovative compounds tailored to individual patient needs. This market is driven by a combination of factors including rising cancer incidences, technological advancements, and increasing investments in healthcare infrastructure.
The increasing prevalence of cancer and the demand for personalized treatment options are driving the growth of the compounding chemotherapy market in Israel. Additionally, advancements in pharmaceutical manufacturing techniques and the rising adoption of compounding pharmacies are contributing to market expansion.
Despite advancements in medical technology and the increasing demand for personalized treatment options, the compounding chemotherapy market in Israel faces challenges related to regulatory compliance and quality control. Ensuring consistency in compound formulations while adhering to strict safety standards remains a significant hurdle for manufacturers and healthcare providers.
Israel healthcare system fosters a robust market for compounding chemotherapy, ensuring accessibility and quality care for patients. The government plays a significant role in regulating this sector, ensuring safety standards and efficacy in the production and administration of chemotherapy drugs. Policies prioritize patient welfare, driving innovation and research in personalized medicine approaches.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Compounding Chemotherapy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Compounding Chemotherapy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Compounding Chemotherapy Market - Industry Life Cycle |
3.4 Israel Compounding Chemotherapy Market - Porter's Five Forces |
3.5 Israel Compounding Chemotherapy Market Revenues & Volume Share, By Dose type, 2021 & 2031F |
3.6 Israel Compounding Chemotherapy Market Revenues & Volume Share, By Compounding Type, 2021 & 2031F |
3.7 Israel Compounding Chemotherapy Market Revenues & Volume Share, By Delivery method, 2021 & 2031F |
3.8 Israel Compounding Chemotherapy Market Revenues & Volume Share, By Sterility, 2021 & 2031F |
3.9 Israel Compounding Chemotherapy Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Israel Compounding Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in compounding chemotherapy procedures |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for compounding chemotherapy |
4.3.2 High cost associated with personalized medicine |
4.3.3 Limited availability of skilled healthcare professionals |
5 Israel Compounding Chemotherapy Market Trends |
6 Israel Compounding Chemotherapy Market Segmentations |
6.1 Israel Compounding Chemotherapy Market, By Dose type |
6.1.1 Overview and Analysis |
6.1.2 Israel Compounding Chemotherapy Market Revenues & Volume, By Chemotherapeutic, 2021-2031F |
6.1.3 Israel Compounding Chemotherapy Market Revenues & Volume, By Non-chemotherapeutic, 2021-2031F |
6.1.4 Israel Compounding Chemotherapy Market Revenues & Volume, By Others, 2021-2031F |
6.2 Israel Compounding Chemotherapy Market, By Compounding Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Compounding Chemotherapy Market Revenues & Volume, By Pharmaceutical Ingredient Alteration, 2021-2031F |
6.2.3 Israel Compounding Chemotherapy Market Revenues & Volume, By Currently Unavailable Pharmaceutical Manufacturing, 2021-2031F |
6.2.4 Israel Compounding Chemotherapy Market Revenues & Volume, By Pharmaceutical Dosage Alteration, 2021-2031F |
6.3 Israel Compounding Chemotherapy Market, By Delivery method |
6.3.1 Overview and Analysis |
6.3.2 Israel Compounding Chemotherapy Market Revenues & Volume, By Gravimetric automated Compounding Device, 2021-2031F |
6.3.3 Israel Compounding Chemotherapy Market Revenues & Volume, By Volumetric Automated Compounding Device, 2021-2031F |
6.4 Israel Compounding Chemotherapy Market, By Sterility |
6.4.1 Overview and Analysis |
6.4.2 Israel Compounding Chemotherapy Market Revenues & Volume, By Sterile, 2021-2031F |
6.4.3 Israel Compounding Chemotherapy Market Revenues & Volume, By Non-sterile, 2021-2031F |
6.5 Israel Compounding Chemotherapy Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Israel Compounding Chemotherapy Market Revenues & Volume, By With Robotic arm, 2021-2031F |
6.5.3 Israel Compounding Chemotherapy Market Revenues & Volume, By Without Robotic Arm, 2021-2031F |
7 Israel Compounding Chemotherapy Market Import-Export Trade Statistics |
7.1 Israel Compounding Chemotherapy Market Export to Major Countries |
7.2 Israel Compounding Chemotherapy Market Imports from Major Countries |
8 Israel Compounding Chemotherapy Market Key Performance Indicators |
8.1 Average turnaround time for compounding chemotherapy prescriptions |
8.2 Number of new partnerships with pharmaceutical companies for drug development |
8.3 Rate of adoption of novel compounding technologies |
8.4 Percentage of patients opting for personalized medicine treatments |
8.5 Number of clinical trials involving compounding chemotherapy treatments |
9 Israel Compounding Chemotherapy Market - Opportunity Assessment |
9.1 Israel Compounding Chemotherapy Market Opportunity Assessment, By Dose type, 2021 & 2031F |
9.2 Israel Compounding Chemotherapy Market Opportunity Assessment, By Compounding Type, 2021 & 2031F |
9.3 Israel Compounding Chemotherapy Market Opportunity Assessment, By Delivery method, 2021 & 2031F |
9.4 Israel Compounding Chemotherapy Market Opportunity Assessment, By Sterility, 2021 & 2031F |
9.5 Israel Compounding Chemotherapy Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Israel Compounding Chemotherapy Market - Competitive Landscape |
10.1 Israel Compounding Chemotherapy Market Revenue Share, By Companies, 2024 |
10.2 Israel Compounding Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |